Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2026-05-22 @ 6:53 AM
Study NCT ID:
NCT00213135
Status:
COMPLETED
Last Update Posted:
2014-02-07
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
Sponsor:
EMD Serono
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Sclerosis, Relapsing-Remitting | View |
Keywords: